Airway Clearance Devices Market
Number of pages: 100 | Report Format: PDF | Published date: March 23, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 594 million |
|
Revenue Forecast in 2031 |
US$ 986 million |
|
CAGR |
5.8% |
|
Base Year for Estimation |
2022 |
|
Forecast Period |
2023-2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Type, Application, End-user, and Region. |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global airway clearance devices market was valued at US$ 594 million in 2022 and is expected to register a revenue CAGR of 5.8% to reach US$ 986 million by 2031.
Airway Clearance Devices Market Fundamentals
The global airway clearing devices market is growing due to the rapidly aging population, the rising prevalence of respiratory conditions, such as cystic fibrosis and COPD, and technological developments. The market is expected to grow due to rising healthcare costs and expanding public awareness of the advantages of airway-clearing therapy.
The airway clearance devices market is highly competitive, with several key players, such as Hill-Rom Holdings Inc., Koninklijke Philips N.V., and Electromed, Inc. These companies are investing in research and development to improve product efficiency and effectiveness and expand their product offerings. In terms of region, North America is the largest market for airway clearance devices, followed by Europe and Asia Pacific. The rising prevalence of respiratory diseases and the increasing healthcare expenditure in these regions drive market revenue growth.
[5765]
Airway Clearance Devices Market Dynamics
The rising incidence of respiratory diseases, such as COPD, cystic fibrosis, and bronchiectasis, is driving the demand for airway clearance devices, which can help patients to manage their condition by removing mucus and other secretions from their airways, improving breathing, and reducing the risk of respiratory infections. According to the Global Initiative for Chronic Obstructive Lung Disease, an estimated 200 million people have COPD, of which about 3.2 million die each year globally. Advances in technology are driving the development of new and innovative airway clearance devices. These include devices that use high-frequency air pulses, positive pressure, and oscillation to clear the airways. Additionally, integrating smart technology and machine learning is leading to the development of more personalized and effective treatments.
A growing awareness among healthcare providers and patients about the benefits of airway clearance therapy for respiratory conditions is leading to greater demand for airway clearance devices and more widespread adoption of these therapies. Moreover, manufacturers are increasing their focus on designing airway clearance devices that are comfortable for patients to use and easy to operate. The rising incorporation of features, such as quieter operation, ergonomic design, and intuitive controls, in the latest devices is propelling the revenue growth of the airway clearance devices market. Governments and healthcare providers are investing more in respiratory care, including airway clearance therapy. This is leading to greater adoption of airway clearance devices.
However, the high cost of airway clearance devices is restricting the revenue growth of the market. In some countries, airway clearance devices may not be fully reimbursed by insurance companies or healthcare systems, which is also cramping the revenue growth of the airway clearance devices market.
Airway Clearance Devices Market Ecosystem
The global airway clearance devices market is analyzed from four perspectives: type, application, end-user, and region.
Airway Clearance Devices Market by Type
[9676]
Based on the type, the global airway clearance devices market is segmented into positive expiratory pressure (PEP), flutter mucus clearance devices, high-frequency chest wall oscillation (HFCWO), intrapulmonary percussive ventilation (IPV), and others.
The flutter mucus clearance devices segment dominated the airway clearance devices market with the largest revenue share. The flutter mucus clearance devices effectively improve lung function and reduce exacerbations in patients with various respiratory conditions. The flutter mucus clearance devices are easy to use and do not require any external power source, making them a convenient option for patients to use at home. The flutter mucus clearance device has been on the market for several years and has a well-established market presence. This has helped to build trust among patients and healthcare providers and has led to high adoption rates. The device is portable and can be easily carried by patients when traveling. It is also relatively cost-effective compared to other airway clearance devices, making it accessible to a larger patient population, thus boosting segment revenue growth.
Airway Clearance Devices Market by Application
Based on the application, the global airway clearance devices market is segmented into cystic fibrosis, bronchiectasis, COPD, and others.
The rising prevalence of cystic fibrosis worldwide is boosting segment revenue growth. According to the National Center for Biotechnology Information, an estimated 105,352 people are diagnosed with cystic fibrosis globally. Cystic fibrosis affects the lungs and other organs, causing thick and sticky mucus to build up in the airways. This mucus can obstruct the airways, making breathing difficult and increasing the risk of lung infections, thus increasing the uptake of airway clearance devices. Cystic fibrosis patients typically require daily airway clearance therapy, which has led to high demand for airway clearance devices in this patient population. In many countries, airway clearance devices are fully reimbursed for cystic fibrosis patients, making them more accessible and affordable for this patient population. There are well-established clinical guidelines for managing cystic fibrosis, including recommendations for airway clearance devices. This has helped to build trust among healthcare providers and has led to high adoption rates of airway clearance devices in the cystic fibrosis patient population.
Bronchiectasis is a very common respiratory condition. According to the National Center for Biotechnology Information, the prevalence of bronchiectasis ranges from 67 to 566.1 per 100,000 inhabitants in Europe and North America, creating a significant market opportunity for airway clearance devices in the patient population. The airway clearance needs of bronchiectasis patients are similar to those of cystic fibrosis patients, requiring daily airway clearance therapy to remove excess mucus and reduce the risk of lung infections. This has led to the adoption of airway clearance devices in the bronchiectasis patient population. There are limited alternative therapies for bronchiectasis patients, making airway clearance devices an essential component of their treatment regimen.
Airway Clearance Devices Market by End-user
Based on the end-user, the global airway clearance devices market is segmented into hospitals & clinics, home care settings, ambulatory surgical centers, and others.
The home care settings segment accounted for a significant revenue share of the airway clearance devices market. There is a growing trend towards home-based care for patients with chronic respiratory diseases. It can provide a more convenient and cost-effective option than hospital-based care. This has led to an increase in demand for airway clearance devices in home care settings. The development of portable and easy-to-use airway clearance devices has made it possible for patients to perform airway clearance therapy at home without needing assistance from healthcare providers. This has boosted the demand for airway clearance devices in home care settings.
The hospitals & clinics segment is also expected to account for a considerable revenue share of the airway clearance devices market. Patients with chronic respiratory diseases may experience acute exacerbations that require hospitalization or treatment in a clinical setting. Airway clearance devices are often used as part of the treatment regimen for these patients, leading to high demand in hospitals and clinics, which have specialized healthcare providers, such as respiratory therapists, trained in airway clearance devices and can guide and support patients. This has led to the high adoption of airway clearance devices in hospitals and clinics. Moreover, hospitals and clinics often have access to advanced airway clearance devices unavailable in-home care settings. This has further increased the adoption of airway clearance devices in hospitals and clinics. Airway clearance devices are often used in emergency care settings, such as emergency departments and intensive care units, to help patients with acute respiratory distress.
Airway Clearance Devices Market by Region
Geographically, the global airway clearance devices market has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America accounted for a significant market revenue share in 2022. North America has a high prevalence of chronic respiratory diseases, such as cystic fibrosis, bronchiectasis, and COPD, which require airway clearance therapy. This has led to significant demand for airway clearance devices in the region. According to the Cystic Fibrosis Foundation, approximately 40,000 children and adults live with cystic fibrosis in the United States. North America is home to some of the world’s leading manufacturers of airway clearance devices, who have developed technologically advanced devices that are more effective and easier to use. This has further increased the demand for airway clearance devices in the region. North America has a high concentration of specialized healthcare providers, such as respiratory therapists, who are trained in airway clearance devices and can provide guidance and support to patients. This has contributed to the region’s high adoption of airway clearance devices. There is a growing trend towards home-based care in North America, as it can provide a more convenient and cost-effective option than hospital-based care. This has increased the demand for airway clearance devices in the home care settings segment.
Airway Clearance Devices Market Competitive Landscape
The prominent players operating in the global airway clearance devices market are:
Airway Clearance Devices Market Strategic Developments
The global airway clearance devices market is expected to reach US$ 986 million by 2031.
The global airway clearance devices market is estimated to register a revenue CAGR of 5.8% during the forecast period.
The prominent players operating in the global airway clearance devices market are Hill-Rom Services Inc., Koninklijke Philips N.V., Electromed Inc., Smiths Medical (ICU Medical, Inc.), and General Physiotherapy, Inc.
Asia Pacific accounts for the highest revenue growth rate, which can be considered the key region due to the rapid market developments due to the rise in the patient pool and penetration of international market players.
The flutter mucus clearance device segment dominates the global airway clearance devices market with the largest revenue share.
*Insights on financial performance are subject to the availability of information in the public domain